USF Home Page
-
A-Z Index
-
Campus Directory
-
USF Search
UNIVERSITY OF SOUTH FLORIDA
USF Health
|
College of Medicine
|
College of Nursing
|
College of Public Health
|
School of Physical Therapy & Rehabilitation Sciences
|
USF Health Office of Research
|
Clinical Studies
|
My Healthcare at USF Health
|
Shimberg Health Sciences Library
|
USF Health Human Resources
|
USF Health Alumni Office
|
Giving to USF Health
|
USF Health Information Systems
|
Print Friendly
|
USF Home
>
USF Health Home
>
Morsani College of Medicine
>
Internal Medicine
>
Infectious Diseases and International Medicine
>
Hepatitis C Evaluation and Technical Assistance Center (ETAC)
>
Research Publications
USF Hepatitis C Evaluation and Technical Assistance Center
USF Health ETAC
Home
ETAC Research Team
Evaluation Sites
Resources for Patients
Resources for Physicians
Multi-Site Conference Calls
Research Publications
Partners
Data Collection Forms
Events
Contact Us
ETAC Calendar
AIDS.gov
The AIDS Institute
Research Publications
Addressing Coinfection with Viral Hepatitis
Viral Hepatitis Updates from CDC
The Economic Burden of Hepatitis C-Associated Diseases
Updated Boceprevir (Victrelis) Label Adds Data on Prior Null Responders
Severe Stomatitis Complicating Treatment With Pegylated-Interferon and Ribavirin in an HCV-Infected Patient
New Agents for the Treatment of Hepatitis C Virus — Focus on Telaprevir
Acute Hepatitis C Infection in HIV-Positive Patients
Clinical Presentation and Course of Acute Hepatitis C Infection in HIV-Infected Patients
IL28B Polymorphism Improves Viral Kinetics and is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
IL28B Genomic-Based Treatment Paradigms for Patients with Chronic Hepatitis C Infection: The Future of Personalized HCV Therapies
Genetic Variation in IL28B: Impact on Drug Development for Chronic Hepatitis C Infection
Addressing Comorbidities: The Hepatitis C Treatment Expansion Initiative
A Clinician's Guide To HIV and Hepatitis A,B,C
A Guide for Evaluation and Treamtent of Hepatitis C in Adults Co-infected with HIV
A New Era of Hepatitis C Therapy Begins
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
Hepatitis A and B Immunization in Persons Infected with HIV
Hepatitis C in HIV Infected Patients 101
Treatment Initiation and Monitoring in HIV/HCV Co-infected Patients
PEG-IFN Induced Interstitial Pneumonitis in Hepatitis C
Ocular Complications of PEG-Interferon
Peginterferon alpha and Ribavirin for Chronic Hepatitis C
(
Click here
for summary only)
Optimal Control of Hepatitis C Antiviral Treatment Programme Delivery for Prevention Amongst a Population of Injecting Drug Users
Mathematical Modelling of Hepatitis C Treatment for Injectinng Drug Users
PROTON Study: PSI-7977 QD with PEG/RBV - 12 Week Safety, RVR, cEVR, & SVR12 in Treatment-Naive Patients with HCV GT2 or GT3
A Guide for Evaluation and Treatment of Hepatitis C in Adults Coinfected with HIV
EASL Clinical Practice Guidelines: Management of Hepatitis C Virus Infection
An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
FDA Grants Waiver for OraQuick HCV Rapid Test
